An Israeli CEO’s biotech firm said on Sunday that it is seeking UK emergency approval for its “revolutionary” coronavirus-busting nasal spray. The Canadian company co-founded by Dr. Gilly Regev, called SaNOtize, says its nitric oxide spray was designed to “kill the virus in the upper airways, preventing it from incubating and spreading to the lungs.” Read more...
Read MoreVANCOUVER, British Columbia & SURREY, England–(BUSINESS WIRE)–Biotech company SaNOtize Research & Development Corp., (SaNOtize), Ashford and St Peter’s Hospitals NHS Foundation Trust in Surrey, UK, and Berkshire and Surrey Pathology Services, UK, today announced results of clinical trials indicating that SaNOtize’s Nitric Oxide Nasal Spray (NONS) represents a safe and effective antiviral treatment that could prevent the transmission of COVID-19, shorten its course, and reduce the severity of symptoms and damage in those already infected. Register...
Read MoreAI has opened doors for use of smart tech to assist people in day to day life, be it increased convenience in personal life or ease of access to public services. Stimulating the human brain via medtech has also proved to be successful in helping people with neurological ailments, and the technique has even helped Emirati authorities decode a criminal’s mind. Read more...
Read MoreA machine vision-based blood analyzer has been made part of an assessment of an AI-based test to rapidly screen for COVID-19 in patients arriving in emergency departments. Read more...
Read MoreSpectrum Health, one of the top-rated health systems in the US, is partnering with telehealth company TytoCare to expand its virtual care and remote patient monitoring offerings. Based in Michigan, Spectrum is expanding its telehealth offerings by integrating TytoCare into its services, giving clinicians the ability to diagnose and treat patients remotely with TytoCare’s handheld AI-powered examination kit. Read...
Read More
